Wikidata

(Q51711886)

English

IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis.

scientific article published in March 2008

In more languages

Statements

title
IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18322974
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18322974%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q51711886&oldid=1260391752"